Overview
This Webcast provides overview on usage of the New Antiviral Remdesivir introduced for treatment of COVID – 19 and Challenges in the management of COVID – 19 patients.
Faculty
Dr. Matteo Bassetti
MD PHD
Prof. of Infectious Diseases, Dept. of Health Science, Univ. of Genoa Head, Infectious Diseases Clinic, Hosp. Policlinico San Martino IRCCS, Italy.
Dr. Jaideep Gogtay
MBBS, MDExecutive Vice President and Global Chief Medical Officer, Cipla, Mumbai, India
Dr. Vasant Nagvekar
MD (Med) FIDSA Conurant Infection Disease Llave Hospital, Mumbai Joint Director MN Reliance hospital, MumbaiDepartment of Infectious diseases, Fellowship ID, Lilavati Hospital, Mumbai, IndiaDr Yatin Mehta
MD, DNB, FRCAChairman, Institute of Critical Care and Anesthesiology, Medanta Hospital, Gurgaon, India
Dr. Harjit Dumra
MBBS, MD (Internal Medicine)Consultant Interventional Pulmonologist Sleep Medicine and Critical Care Specialist Sterling Hospital Head, Dept of Critical Care, Sterling Hospital Director, Sparsh Chest Disease Center, Gujarat, India
Dr Rashmi Hegde
Vice-President, Medical Affairs, Cipla Ltd. Mumbai, IndiaVice-President, Medical Affairs, Cipla Ltd. Mumbai, IndiaResources
External Resources
REMDESIVIR: Evidence to Experience
Also Read
